Abstract Rationale: Dopaminergic neurotransmission is critically involved in many aspects of complex behavior and cognition beyond reward/reinforcement and motor function. Mental and behavioral disorders associated with major disruptions of dopamine neurotransmission, including schizophrenia, attention deficit/hyperactivity disorder, Parkinson's disease, Huntington's disease, and substance abuse produce constellations of neuropsychological deficits in learning, memory, and attention in addition to other defining symptoms. Objective: To delineate the role dopaminergic D 1 -and D 2 -like receptor subtypes play in complex brain functions. Materials and methods: Monkeys (N=6) were trained on cognitive tests adapted from a human neuropsychological assessment battery (CAmbridge Neuropsychological Test Automated Battery). The battery included tests of spatial working memory (self-ordered spatial search task), visuo-spatial associative memory and learning (visuo-spatial paired associates learning task, vsPAL) and motivation (progressive ratio task, PR). Tests of motor function (bimanual motor skill task, BMS; rotating turntable task, RTT) were also included. The effects of the dopamine D 2 -like antagonist raclopride (10-56 μg/kg, i.m.) and the D 1 -like antagonist SCH23390 (SCH, 3.2-56 μg/kg, i.m.) on cognitive performance were then determined. Results: Deficits on PR, RTT, and BMS performance were observed after both raclopride and SCH23390. Spatial working memory accuracy was reduced to a greater extent by raclopride than by SCH, which was unexpected, given prior reports on the involvement of D 1 signaling for spatial working memory in monkeys. Deficits were observed on vsPAL performance after raclopride, but not after SCH23390.
Introduction
Dopaminergic signaling in the central nervous system (CNS) plays a clear role in many aspects of complex behavior and cognition. Mental and behavioral disorders associated with major disruptions of dopamine (DA) neurotransmission include normal aging, schizophrenia, attention deficit/hyperactivity disorder (ADHD), Parkinson's disease (PD), Huntington's disease (HD), and substance abuse. These conditions are associated with neuropsychological impairment of learning, memory, sustained attention, and motor function, and these deficits are thought to be related to alterations in dopamine neurotransmission. Positive associations of cognitive performance with dopamine transporter (DAT), dopamine D 2 -and/or D 1 -like receptor binding in the striatum, have been reported in PD (Duchesne et al. 2002; Muller et al. 2000) , in HD (Backman et al. 1997; Lawrence et al. 1998) , and in methamphetamine abusers (Volkow et al. 2001b ). Dopamine receptor binding in prefrontal cortical regions is also correlated with cognitive performance on tasks of executive function in PD . A reduced orbito-frontal activity has been correlated with low D 2 -like receptor binding in the striatum of methamphetamine abusers (Volkow et al. 2001a) .
The neuropsychological deficits of learning, memory, and attention were not originally considered primary therapeutic targets in pharmacological treatments in these disorders. Success in treating primary symptoms pharmacologically (i.e., motor function in PD, hallucinations/ delusions in schizophrenia, etc.) has permitted a current focus on mnemonic and attentional symptoms. The relative lack of treatment success with traditional approaches in substance abuse has driven research to study attentional and associative mechanisms that may be co-opted by drug exposure. Further understanding of the role dopaminergic signaling plays in aspects of complex behavior and neuropsychological brain functioning may assist with the development of novel therapeutic measures. The importance of understanding mechanisms subserving higher cognitive function is important well beyond traditional mental disorders. For example relative attentional, learning, and executive inability, as opposed to outright dysfunction, may have a significant effect on the performance of physicians (Perry and Crean 2005) .
Given the diversity of cognitive and behavioral impairments associated with disrupted DA neurotransmission in a variety of clinical populations, developing nonhuman models to assess D 1 and D 2 receptor functions on a range of well-defined cognitive tasks is of substantial importance. Previous studies of the role of dopaminergic signaling in nonhuman primate behavioral models have primarily focused on reinforcement processes (Bergman et al. 1991; Campbell et al. 1999; Gasior et al. 2004; Sinnott et al. 1999; Tidey and Bergman 1998; Woolverton and Virus 1989) , and on a single assay of spatial memory, the twoalternative delayed response (DR) task or its oculo-motor counterpart (Arnsten et al. 1994; Arnsten et al. 1995; Sawaguchi 2001) . The oculo-motor version of the spatial delayed response task has provided evidence for an optimal range of D 1 signaling in primate prefrontal cortex for spatial working memory (Williams and Goldman-Rakic 1995) . Because of the restricted cognitive range of such studies, important questions remain regarding the behavioral and pharmacological selectivity of dopaminergic signaling in complex cognition. If other tasks accessing other cognitive domains are not evaluated, it is not possible to conclude that a given manipulation is specific to a single cognitive domain such as "spatial working memory".
Previous research has reported impaired performance on tasks of spatial working memory after administration of a D 1 -like antagonist (Arnsten et al. 1994; Sawaguchi 2001) . It was hypothesized that the D 1 -like antagonist SCH23390 would impair performance on the self-ordered spatial search (SOSS) task, which is a more complex spatial working memory task. It was further predicted that the D 2 -selective antagonist raclopride would preferentially impair performance on the visuo-spatial paired-associate learning (vsPAL) task due to previous reports of a loss of D 2 expression in inferior temporal regions (Joyce et al. 1998) which have been associated with object-in-place memory in monkeys (Malkova and Mishkin 2003) and findings of impaired memory after D 2 -like antagonists (Arnsten et al. 1995; Mehta et al. 2001) . The effects on progressive ratio (PR), rotating turntable (RTT), and bimanual motor skill (BMS) tasks are predicted to be similar for the two compounds on the basis of prior results with drug-or foodreinforced responding (Nader et al. 2002; Woolverton and Virus 1989) and motor function assays in monkeys.
The present investigation was designed to identify differential contributions made by DA receptor classes to multiple aspects of cognitive performance in rhesus monkeys. Dopaminergic manipulation was conducted via acute challenge with the D 1 -like antagonist SCH23390 and the D 2 -like antagonist raclopride. The monkeys were assessed on tests that have been previously shown to be selectively affected or differentially sensitive to a number of acute pharmacological challenges in rhesus monkeys including cholinergic (Katner et al. 2004a; Taffe et al. 1999 Taffe et al. , 2002c , glutamatergic (Taffe et al. 2002a,c) , and serotonergic (Taffe et al. 2002b (Taffe et al. , 2003b manipulations. Performance is also affected by neurotropic viral infection Weed et al. 2004) , alcohol consumption (Katner et al. 2004b) , aging process (Taffe et al. 2003a) , and experimental changes in motivational status (Taffe 2004; Weed et al. 1999 ). The present study aimed to determine the effects of systemic challenge with dopaminergic compounds across a range of behaviors. The results can, therefore, contribute to the development of more refined psychotherapeutics. The overall goal is to differentiate DA receptor contributions to multiple aspects of cognition and, thus, contribute to a more comprehensive understanding of the role of D 1 -and D 2 -like receptors in cognitive and motor functions. The data obtained may offer further insight into cognitive declines related to neurological and psychiatric disorders as well as determining the manner in which D 1 -and D 2 -like receptors contribute to normal cognitive function.
Materials and methods

Animals
Six young adult male rhesus macaques (Macaca mulatta) served as subjects. The monkeys were approximately 3-4 years of age and weighed 3.8-6.4 kg at the beginning of the study. The animals were individually housed and fed in the home cage after completion of the daily testing session. The animals' normal diet (Lab Diet 5038, PMI Nutrition International, 3.22 kcal of metabolizable energy per gram) was supplemented with fruit or vegetables 7 days per week and water was available ad libitum in the home cage at all times. The animals' normal chow allotment (∼200-250 g/ day) was individually adjusted and modestly restricted 5 days per week to ensure consistent behavioral responding. Adequate growth rates within one SD of published norms for free ranging (Rawlins et al. 1984 ) and laboratory-housed (Schapiro and Kessel 1993) male rhesus monkeys were maintained. Individual M-F minimum chow amounts ranged from 95 to 155 g/day and maximum chow amounts ranged from 115 to 180 g/day through the course of these studies. Prior experience with this food restriction protocol produces a mean growth rate of 0.06 kg/month before puberty and 0.14 kg/month thereafter for animals 2-8 years of age. The subjects had received acute doses of ketamine (5-20 mg/kg) no less than semiannually for routine care and acute doses of raclopride, methylphenidate, scopolamine, and d-amphetamine in prior behavioral studies. The United States National Institutes of Health guidelines for laboratory animal care (Clark et al. 1997) were followed and all protocols were approved by the Institutional Animal Care and Use Committee of the Scripps Research Institute. All animals were trained on the behavioral testing battery which has been previously described Weed et al. 1999 ).
Behavioral testing
Performance was evaluated using a battery of tests designed to model specific cognitive domains in rhesus monkeys Weed et al. 1999) . The battery included tests of learning (visuo-spatial paired-associate learning), memory (self-ordered spatial search), sustained attention and reinforcer efficacy (progressive ratio), bimanual motor coordination (bimanual motor skill), and unimanual motor tracking (rotating turntable). The monkeys were tested 5 days/week (Monday-Friday) on the task battery, completing either PR and SWM and RTT, vsPAL or PR and RTT on alternate days and BMS each day. This schedule was adapted slightly from the typical schedule used in prior studies (Katner et al. 2004a; Taffe et al. 2002a ) because of the anticipated short duration of action of the test compounds. The order of the three session types relative to the testing week and, therefore, each treatment condition was randomized across subjects.
Apparatus
For behavioral testing, the animals were transferred to transport cages similar to the home cage and were tested either in the colony room or in smaller isolated rooms. Our experience using this paradigm shows that any potential differences in performance attributable to testing location are much smaller than individual differences. This is perhaps because the motivational control and within-task observing response requirements minimize gross distraction or because the isolated rooms are not insulated, thus some degree of auditory distraction is still possible. The transport cage was placed in front of a touch-sensitive computer monitor and all animals had been previously trained to reach out of the cage to touch the location on the screen at which visual stimuli were presented to obtain a food pellet reward. The test battery consisted of five alternating behavioral tasks. Three of the tasks (vsPAL, SOSS, and PR) are part of the nonhuman primate CAmbridge Neuropsychological Test Automated Battery (CANTAB, Cambridge Cognition, Cambridge, UK). BMS required the animal to extract raisins from holes in a transparent polycarbonate board and RTT required the animal to retrieve pellets from a rotating turntable. Comprehensive descriptions of the individual tasks and the procedural details have been previously reported (Taffe et al. 2002c , 2004 Taffe 2004 Weed et al. 1999 ); however, a brief description follows. The time required to train the tasks for these particular subjects was highly consistent with data presented in those prior methodological reports.
Progressive ratio (PR) schedule of reinforcement
The PR task was designed to measure sustained attention and reinforcer efficacy. The subjects were required to respond to a single colored rectangle presented in the center of the screen for pellet reinforcement. The response requirement started at one touch and incremented by arithmetic progression within blocks of eight reinforcers and by geometric progression between blocks of eight. The session was terminated after 10 min or earlier if 3 min elapsed after a response. The interval between session start and the last response emitted was recorded as the time-tolast-response measure. Sustained attention is thought to be indexed by total number of responses made and reward efficacy is traditionally indexed by number of reinforcers acquired.
Bimanual motor skill task
The BMS task was designed to measure fine motor coordination. A transparent polycarbonate board (10-cm wide × 25-cm high × 2.75-cm thick) drilled with 15 holes (spaced 13 mm apart in a three horizontal × five vertical array) was filled with raisins and mounted perpendicular to the door of the transport cage. The subjects were required to push the raisin out of the hole with one finger before retrieving it with the opposite hand, thus entailing bimanual dexterity. The time elapsed to retrieve all 15 raisins was recorded as a change from percentage baseline performance in retrieval latency.
Rotating turntable task
The RTT task was designed to assess unimanual motor coordination, procedural learning, and visual tracking of moving objects. A 58-cm opaque white plastic disk containing short radial slots at the edge was mounted to a motor controlled from 0-150 rpm by rheostat. The subjects were required to retrieve six of ten pellets from the slots for a "pass". The trial is considered failed if the subject failed to retrieve or dropped five of ten pellets. Turntable speed is increased after passed trials and decreased after failed trials in a titration procedure. The final maximum speed (retrieval threshold) for a given session was the highest "passed" speed before three failed attempts.
Self-ordered spatial search
The SOSS task was designed to measure spatial working memory. Two, three, or four small, colored rectangles (boxes) were displayed on the screen in positions randomly allocated from 16 possible locations. The subjects were required to select all boxes without revisiting a box once it had been touched. A session consisted of 30 trials grouped into six blocks by trial type as follows: five (two boxes), five (three boxes), five (four boxes), five (three boxes), five (four boxes), and five (two boxes). Accuracy scores were calculated for each trial type by dividing the number of correctly completed trials by the number of trials in which there was at least one response. Trial latency was the average time a subject required to touch all boxes for correctly completed trials.
Visuo-spatial paired associates learning
The vsPAL task was designed to measure associative and procedural learning, and memory. The subjects were required to learn and remember the spatial location of visual patterns. In brief, colored abstract stimuli were displayed in one of four possible target locations and the subject was required to touch this sample stimulus, which then disappears. After a 1-s screen blank, the same pattern reappeared (choice phase) in two or four locations on the screen (the original location plus one or more novel locations). The subject was required to touch the stimulus that is presented in the same location as the sample item to obtain a reinforcer. The subjects were allowed up to five additional attempts to successfully complete the set of stimulus-location associations in a given trial, thus measuring incremental learning. Each session consisted of 20 trials in sequential blocks including ten × twostimulus trials and ten × four-stimuli trials. Performance was measured by percent correct on the initial attempt to complete a trial and the percent correct of trials successfully completed within the allowed attempts (overall completion). The initial attempt score is interpreted as a memory measure and the difference between overall completion rates and initial attempt rates are interpreted as a measure of learning. Additional measures of performance include the initial-attempt choice accuracy (proportion of correct choices on the first attempt, task completion (proportion of trials which both sample and choice responses were made), total number of correct choices, total number of incorrect choices, mean sample latency (response time for all observing responses), and mean choice latency (response time for all correct choice responses).
Acute drug challenge procedure
The animals received drug injections of dopamine-like antagonists raclopride and SCH23390 (each compound dissolved with physiological saline to obtain a constant injection volume of 0.1 ml/kg) on Tuesdays and Fridays, vehicle (physiological saline, 0.1 ml/kg) injections on Thursdays, and no injections on Mondays and Wednesdays. The monkeys were first challenged with the D 2 -like antagonist raclopride in an ascending dose order (10, 17.8, 32, and 56 μg/kg, i.m.) with a constant injection volume of 0.1 ml/kg. Before initiating the second drug challenge, a washout period of a minimum of 3 weeks was employed that consisted of physiological saline, 0.1 ml/kg, injected 3 days per week (Tue, Thur, Fri) until performance after injections was equivalent to non-injection performance. After the washout period, the same monkeys were challenged with the D 1 -like antagonist SCH23390 in an ascending dose order (3.2, 10, 17.8, 32, and 56 μg/kg, i.m.) with a constant injection volume of 0.1 ml/kg. Each dose of raclopride and SCH23390 was evaluated once for SOSS, PAL, or PR, twice for RTT, and thrice for BMS. The pretreatment intervals were as illustrated in Fig. 1 . The mean performance of an individual for all sessions run under a given treatment condition was generally used for analyses. One exception was made to this rule because a preliminary inspection of the data suggested a clear pharmacokinetic effect for each drug, that is, BMS doseresponse functions were similar for the shorter two session types ( Fig. 1; session 2, 3 ), but no effect was observed for the longer session type. Consistent with this interpretation, the earlier-run two-stimulus trials of the vsPAL task appeared affected whereas the four-stimulus trials appeared unaffected. Thus, it was concluded that behaviorally relevant levels of challenge drug were no longer present by approximately 55-60 min post-injection. The BMS data for the longest session and four-stimulus trial data for vsPAL were, therefore, not analyzed nor presented. One Fig. 1 Session schedule. The approximate timing for the three types of behavioral sessions run in rotation on successive test sessions is outlined. The effective pre-treatment intervals for each of the test compounds varied slightly depending on the behavioral task, as illustrated. The challenge studies for raclopride and SCH23390 were run sequentially with a minimum 3-week interval between studies. Preliminary analyses suggested the each compound lost significant behavioral activity after about 60 min (see "Materials and methods" for data treatment) individual (#413) participated in the raclopride study but was not available for the SCH23390 study.
Data analysis
All statistical analyses were conducted using GB-STAT v7.0 for Windows (Dynamic Microsystems, Silver Spring, MD, USA) and the criterion for significance in all tests was p≤0.05. Data for the behavioral tasks were analyzed by repeated-measures analysis of variance (ANOVA). The variables analyzed include the number of reinforcers acquired, the total number of responses, the response rate and the time to last response in the PR task, the retrieval time in the BMS task, and the threshold speed of the turntable at which six of ten pellets could be retrieved in the RTT procedure. Data analyzed for the SOSS task included the percent correct trials and the overall response latency for correct trials for each of the three difficulty conditions (using a two-way ANOVA). Performance measures analyzed for the vsPAL task included the initial-attempt trial completion success, overall trial completion success, percent of correct choices on first attempt, percent task completed, total number of correct choices, total number of incorrect choices, sample latency, and choice latency. The initial attempt trial completion and overall trial completion measures were analyzed with a two-way ANOVA, which was necessary to confirm the learning effect.
Significant effects in the one-way ANOVAs were followed up with post hoc tests using the Dunnett procedure.
Post hoc exploration of significant effects in the two-way designs was conducted using the Tukey-Kramer procedure including all possible pair-wise comparisons.
Results
Progressive ratio task
Raclopride significantly decreased the number of reinforcers acquired (F 5,25 =8.2; p<0.001, the total number of responses (F 5,25 =5.6; p<0.01), the response rate (F 5,25 =4.5; p<0.01), and the time-to-last-response (F 5,25 =3.0; p<0.05) in the PR task as is shown in Fig. 2 . Post hoc analysis confirmed that raclopride significantly altered all PR measures relative to vehicle levels after the 56 μg/kg dose was administered and the total number of responses were significantly reduced compared with vehicle after the 17.8 and 32 μg/kg doses. SCH23390 also significantly decreased the number of reinforcers acquired (F 6,24 =5.8; p<0.001), the total number of responses (F 6,24 =3.6; p<0.05), the response rate (F 6,24 =3.9; p<0.01), and the time-to-last-response (F 6,24 =3.2; p<0.05). Post hoc analysis confirmed that SCH23390 significantly altered all PR measures relative to vehicle levels after the 56 μg/kg dose was administered and the number of reinforcers acquired was significantly lower than vehicle after the 32 μg/kg dose. Fig. 2 Progressive ratio. The mean effect of acute doses of raclopride (N=6; ±SEM) and SCH23390 (N=5; ±SEM) on performance of the PR task is expressed in terms of the number of reinforcers acquired, the time of last response, the total number of responses, and the response rate. A significant difference from the vehicle condition is indicated by an asterisk. Base indicates noninjection baseline sessions; Veh indicates vehicle injection sessions Bimanual motor skill and rotating turntable tasks The speed of raisin retrieval in the BMS task was significantly slowed by both raclopride and SCH23390 as illustrated in Fig. 3a . The mean baseline retrieval latency was 19.9 s (SEM=3.7) in the raclopride condition and 20.2 s (SEM=2.5) in the SCH23390 condition. The repeated-measures ANOVA confirmed a significant main effect of drug treatment condition for the raclopride (F 5,25 =3.0; p<0.05) and SCH23390 (F 6,30 =5.4; p<0.001) challenges. Post hoc exploration of this effect confirmed that significantly longer retrieval times were observed after the 56 μg/kg dose of each compound.
The threshold speed at which animals could retrieve six of ten reinforcers from the rotating turntable was slowed by each compound as shown in Fig. 3b . The mean retrieval threshold was 66.7 rpm (SEM=10.0) for the raclopride study and 86.5 rpm (SEM=9.4) for the SCH23390 study. The repeated-measures ANOVA confirmed a significant main effect of raclopride (F 5,25 =3.5; p<0.05) and SCH23390 (F 6,30 =12.5; p<0.001) with the post hoc test attributing the effect to the 56 μg/kg dose of each compound.
SOSS
Successful trial completion in the SOSS task was significantly reduced by trial difficulty for both the raclopride (F 2,10 =72.0; p<0.001) and SCH23390 (F 2,8 =22.9; p<0.001) challenge studies, as depicted in Fig. 4 . The percentage of trials completed successfully was significantly decreased by the administration of raclopride (F 5,25 =9.3; p<0.001). The Tukey-Kramer post hoc test confirmed a specific effect on three-box performance after the 56 μg/kg dose. There was a trend for SCH23390 to reduce the percentage of trials completed (F 6,24 =2.4; p=0.062). In neither study was any significant interaction between the two main factors observed. There were no significant main effects of trial difficulty on response latency in the raclopride study; however, there was a significant main effect of drug treatment condition raclopride (F 5,25 =3.8; p<0.05 ) and an interaction between trial difficulty and drug treatment (F 10,50 =3.3; p<0.01). A post hoc evaluation of these effects with the Tukey-Kramer procedure confirmed that response latency was significantly slowed for three-box trials after the 56 μg/kg dose. Response latency in the SCH23390 study was significantly affected by trial difficulty (F 2,8 =5.4; p<0.05) and drug treatment condition (F 6,24 =2.8; p<0.05). Further post-hoc exploration with one-way ANOVA (drug condition) for each of the three trial-difficulty types confirmed a significant effect of drug condition on response latency for twobox trials (F 6,24 =3.5; p<0.05) and a non-significant trend for increased response latency for three-box trials (F 6,24 =2.5; p=0.052). A significant increase over vehicle in two-box response latency after the 56 μg/kg dose of SCH23390 was confirmed with the Dunnett procedure.
vsPAL
The predicted learning effect was observed as animals performed significantly more trials correctly when permitted repeated attempts relative to their first attempt accuracy in both raclopride [main effect of completion measure, initial vs overall, (F 1,5 =24.7; p<.01)] and SCH23390 studies (F 1,4 =12.0; p<.05) as illustrated in Fig. 5 . Acute challenge with raclopride interfered with trial completion success [main effect of drug condition; (F 5,25 =3.1; p<.05)], an effect which interacted with completion measure (F 5,25 =3.4; p<.05). Post hoc exploration with the Tukey-Kramer procedure confirmed a significant reduction in initial, but not overall, trial completion success after the 17.8 and 56 μg/kg doses of raclopride. A parallel main effect of drug condition was observed (F 5,25 =2.9; p<.05) when considering the percentage of choices made accurately on the first attempt. The Dunnett post-hoc test confirmed that this was due to a significant reduction in performance after the 17.8 and 56 μg/kg doses. Raclopride also significantly affected the latency to respond to the sample stimuli (F 5,25 =2.8; p<.05), the total number of correct responses (F 5,25 =2.8; p<.05 ) and the percent of the task completed (F 5,25 =7.1; p<.001). A post hoc exploration Fig. 3 Bimanual motor skill and rotating turntable tasks. The mean effect of acute doses of raclopride (N=6; ±SEM) and SCH23390 (N=5; ±SEM) on performance of the BMS and RTT tasks. Data are expressed as a proportion of individual baseline performance levels. A significant difference from the vehicle condition is indicated by an asterisk and Veh indicates vehicle injection sessions of these effects confirmed a significant increase in sample latency, a decrease in total correct responses, and a decrease in the percent of the task completed after the 32 and 56 μg/ kg doses of raclopride. A significant effect of SCH23390 treatment was observed only for the percent of the task completed (F 6,24 =3.8; p<.01) and the Dunnett test confirmed a significant reduction relative to the vehicle condition for the 56 μg/kg doses of SCH23390.
Discussion
The present work shows specific deficits in learning, memory, attention, and motor domains after D 1 and D 2 drug challenges. Similar deficits in performance on the progressive ratio (PR), bimanual motor skill (BMS) and rotating turntable (RTT) tasks were impaired by both raclopride and SCH23390. Clear differences emerged, however, in the context of the memory tasks. Perhaps the most surprising finding was that the SCH23390 challenge did not significantly impair performance on the SOSS task, thought to assess spatial working memory capabilities; however, performance in this task was impaired by raclopride. The D 2 -like, but not the D 1 -like, antagonist also interfered with performance of the visuo-spatial paired associate learning, suggesting that visuo-spatial associative memory depends more on D 2 -like function than it does on D 1 -like neurotransmission, a finding consistent with the a priori hypothesis.
The effects of the DA antagonist compounds on the PR task were clear and consistent with prior work. That is, schedule-controlled responding for shock termination (Bergman et al. 1991) , cocaine (Campbell et al. 1999; Woolverton and Virus 1989) , and food (Nader et al. 2002; Woolverton and Virus 1989) are similarly decreased by D 1 -and D 2 -like antagonist treatment in monkeys. Those results are confirmed and extended here as all measures of PR performance were similarly affected (Fig. 2) .
This outcome suggests a similar impact of each compound on motivation, sustained attention and motor response generation/execution as these have traditionally been applied to PR measures; it is always possible that such distinctions do not hold in the present model. With respect to motivational aspects of PR performance, studies show that nigro-striatal dopaminergic projections (Ljungberg et al. 1991; Schultz et al. 1993a,b) and D 2 -expressing cholinergic interneurons (Watanabe and Kimura 1998) may encode motivation and reward value in a plastic manner. In particular, Watanabe and Kimura (1998) show that learned, reward-associated alterations in striatal neuron discharge rates are attenuated by local application of both D 1 -and D 2 -like antagonists. Thus, it is likely that both the D 1 -and D 2 -like antagonist effects on PR performance are likely to be specific for motivational aspects of the task.
The current results also extend prior findings of deficits in motor execution and production. As with the PR response rate measure, the BMS and RTT results illustrate a consistent involvement of D 1 -and D 2 -like neurotransmission in both bimanual coordinated responses and unimanual tracking and retrieval. Together with a prior report, showing that the effects of D 1 -and D 2 -like antagonists were similar in slowing reaction time , these results confirm the critical involvement of both receptor subtypes in many aspects of motor function. The relatively minimal impact of raclopride and SCH23390 on response latencies in the memory procedures potentially contrasts with this conclusion. However, drug challenges may selectively slow sample vs choice latency in the vsPAL procedure in some cases (present raclopride study, Taffe et al. 2002c ), but not in others (Katner et al. 2004a) , as well as selectively slow choice latency on two-box over four-box trials in the SOSS procedure (Taffe et al. 2002a) . In all cases, the drugs significantly slowed BMS performance. Thus, the response latencies across these tasks are likely determined by different cognitive demands and processes. This evidence together suggests that impaired response latencies in the memory procedures most likely reflect changes in sustained attention, speed/accuracy bias, or mnemonic certainty as opposed to motor capability.
The significant deficits observed after raclopride, without significant effect of SCH23390, on self-ordered spatial Fig. 4 Self-ordered spatial search. The mean effect of acute doses of raclopride (N=6; ±SEM) and SCH23390 (N=5; ±SEM) on performance of the SOSS task are presented in terms of the percentage of trials correctly completed and the response latency for correct trials. The data are presented separately for each of the three trial difficulty levels. A significant pair-wise difference from the vehicle condition is indicated by an asterisk and complete analysis details are provided in the text. Base indicates noninjection baseline sessions; Veh indicates vehicle injection sessions search performance was unexpected. As a caveat, however, it must be appreciated that a non-significant trend for an effect of SCH23390 was observed, thus any contrasting results with raclopride must be interpreted in terms of relative impact rather than presence/absence. Arnsten et al. (1994) have shown that young adult monkeys' performance of the delayed-response task designed to assess spatial working memory is impaired by SCH23390. It is interesting that the impairment in young monkeys was produced at doses which were noticeably sedating, but did not impair performance on a fine motor task. In another study, the D 2 -like agonist quinpirole impaired DR performance at low doses (attributed to D 2 autoreceptor activity) but improved performance at higher doses (Arnsten et al. 1995) . The former effect was ameliorated by raclopride but not SCH23390, whereas the latter effect was reversed by both raclopride and SCH23390, suggesting a role of D 1 -like signaling. Sawaguchi and Goldman-Rakic (1994) have provided more specific evidence using local application of compounds to frontal cortex of monkeys performing an oculomotor version of the delayed response task (ODR). In their study, D 1 -like antagonists SCH23390 and SCH31996 and non-selective antagonist haloperidol all significantly impaired task performance, unlike the D 2 -selective antagonists raclopride and sulpiride.
A possible model to explain the effects of D 1 -vs D 2 -like neurotransmission is suggested by the identification of D 2 -like signaling with response-preparation for memoryguided saccade responses (Wang et al. 2004 ) and D 1 -like signaling with the retention interval (Sawaguchi 1997) . This might suggest a more retention-specific role of D 1 -like receptors; in SOSS, the cognitive load is imposed by the number of locations to be remembered rather than parametric manipulation of retention interval. It is interesting that Collins et al. (1998) found that while the excitotoxic lesions of prefrontal cortex of marmosets impaired SOSS performance, the prefrontal catecholamine lesions induced by 6-hydroxydopamine did not. The catecholamine-depleted group was, however, impaired on acquisition of spatial delayed response suggesting on the face of it that the SOSS may access very different cognitive Fig. 5 Visuo-spatial paired associates learning. The mean effect of acute doses of raclopride (N=6; ±SEM) and SCH23390 (N=5; ±SEM) on performance of the two-stimuli/two-locations vsPAL trials. The data presented in the top panel include the proportion of trials successfully completed on the initial attempt and the overall completion success. The lower panels present the response latency for sample and choice responses, the perresponse choice accuracy on the first attempt at each trial, the total number of correct and incorrect responses, and the percent of the task that was completed. A significant difference from the vehicle condition is indicated by an asterisk. Base indicates noninjection baseline sessions; Veh indicates vehicle injection sessions constructs than delayed response. Experimental manipulation effects on acquisition and stable performance of tasks are, of course, frequently uncorrelated. In addition to this methodological feature, further experiments in the marmosets demonstrated that the excitotoxic lesion impairment of SOSS was abolished if perseverative responding was prevented and remained consistent even when the memory requirement was removed from the task (Collins et al. 1998) . Perseverative responding was not increased by either drug treatment in the present study; thus, it appears that cross-laboratory comparisons are complex, even when the task appears similar in form.
It may alternately be the case that the effects reflect wider circuitry of the brain. For example, delayed matchto-sample, traditionally viewed as a hippocampally dependent task in monkeys, activates dorsolateral prefrontal cortex in addition to hippocampal regions (Porrino et al. 2005) . A conjoint lesion of hippocampus and amygdala conversely impairs spatial delayed response in a manner dependent on retention interval (Zola-Morgan and Squire 1985) . Tasks thought to assess working memory appear to activate fronto-parietal (Schweinsburg et al. 2005 ) as well as fronto-hippocampal (Karlsgodt et al. 2005 ) circuitry in humans. Evidence also suggests that working memory tasks enhance dopamine release in both frontal and temporal regions (Aalto et al. 2005) . Furthermore, in human brain, D 2 -like receptor mRNA is highly expressed in hippocampus which has low expression of D 1 -like receptor mRNA (Hurd et al. 2001) . D 1 -like mRNA is conversely at high levels in the cortex, especially medial orbitofrontal cortex, where D 2 -like mRNA is low. Thus, it is plausible that D 2 -like-receptor-mediated functions of medial temporal structures predominate in determining performance on both SOSS and vsPAL.
The finding that raclopride significantly impaired visuospatial paired associate learning performance where SCH23390 did not is consistent with a growing picture of the dependence of object-location associative memory on specific regions of the temporal lobe memory system. Evidence from prospective studies following elderly individuals with questionable dementia strongly suggest that the capabilities necessary for performance of the vsPAL task decline early in the progression of AD (Blackwell et al. 2004; Fowler et al. 1997 Fowler et al. , 2002 Swainson et al. 2001) . Consistent with this, a preliminary study suggested that aged monkeys may be particularly impaired on this task relative to young adult monkeys (Taffe et al. 2003a) . We have also shown that intact muscarinic and nicotinic cholinergic as well as NMDA receptor glutamatergic neurotransmission is critical for young adult monkeys to perform the task (Katner et al. 2004a; Taffe et al. 2002c) . In this paper, we show that normal D 2 -like, but not D 1 -like, dopaminergic neurotransmission is also required in nonhuman primates for object-location associative memory. The appearance of a significant reduction in performance at a dose (17.8 μg/kg) where most other test battery measures were unaffected also supports a specific role for D 2 -like signaling in vsPAL performance. The pattern of impaired memory but not incremental learning is more similar to the effects of NMDA glutamatergic or nicotinic cholinergic blockade and less similar to muscarinic cholinergic blockade.
The vsPAL finding is consistent with evidence suggesting that object-in-place memory such as required by the vsPAL task may depend specifically on parahippocampal cortical regions (Angeli et al. 1993; Malkova and Mishkin 2003; Parkinson et al. 1988 ) which normally express high levels of D 2 receptors (Goldsmith and Joyce 1994) . This regional specificity of the effect is supported by reports that D 2 -like binding in hippocampal regions is correlated with verbal memory in AD (Kemppainen et al. 2003) , where striatal D 1 -or D 2 -like binding in AD is not correlated (Kemppainen et al. 2000) . Given that there was not even a trend for SCH23390 to affect vsPAL performance here, the present work re-emphasizes the likely priority of temporal vs frontal cortical mechanisms in object-location associative memory.
In summary, the present results suggest that the D 2 -like dopamine receptor antagonist raclopride has a range of detrimental effects on complex behavior indicating D 2 involvement in cognitive constructs such as spatial working memory, visuo-spatial associative memory, fine motor coordination, and motor tracking in addition to reinforcer efficacy and sustained attention. The D 1 -like antagonist SCH23390 produced similar effects on non-mnemonic tasks; however, significant effects on memory tasks were not observed. This intriguing discrepancy from prior work which asserted the primacy of D 1 signalling in spatial working memory tasks suggests the relationships between DA receptor subtypes and various memory capabilities may be much more complex than previously appreciated.
